On the other hand, an exogenous treatment with protein S, a TAM receptor ligand, significantly decreased the levels of inflammatory and profibrotic markers, decreased lung fibrosis, and blocked apoptosis in alveolar ECs [46]. The gene discussed is PROS1; the disease is pulmonary fibrosis.